Key statistics
On Thursday, Pyxis Oncology Inc (PYXS:NSQ) closed at 2.10, 55.56% above the 52 week low of 1.35 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.17 |
---|---|
High | 2.39 |
Low | 1.90 |
Bid | 2.06 |
Offer | 2.10 |
Previous close | 3.82 |
Average volume | 2.77m |
---|---|
Shares outstanding | 59.47m |
Free float | 44.37m |
P/E (TTM) | -- |
Market cap | 124.88m USD |
EPS (TTM) | -1.05 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
- Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
- Pyxis Oncology to Participate in Two Upcoming Investor Conferences
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
- Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference
- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
More ▼